Bristol-Myers Squibb

PriceBristol-Myers Squibb

BMY

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Historical stock price chart and annual return over the past years

41%

5 years

% Total

BMY
7%

5 years

Annual Return

BMY